ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Stock-based compensation (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $718M | +9.0% | 4.0% | 8.6% |
| Stock-based compensation (TTM) | $718M |
|---|---|
| YoY | +9.0% |
| 5-year CAGR | 4.0% |
| 10-year CAGR | 8.6% |
Stock-based compensation
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $664M | −1.3% |
| 2024 | $673M | +4.5% |
| 2023 | $644M | −6.0% |
| 2022 | $685M | +7.0% |
| 2021 | $640M | +17.2% |
| 2020 | $546M | +5.2% |
| 2019 | $519M | +8.8% |
| 2018 | $477M | +17.5% |
| 2017 | $406M | +31.0% |
| 2016 | $310M | +6.2% |
| 2015 | $292M | +18.7% |
| 2014 | $246M | −6.1% |
| 2013 | $262M | −39.5% |
| 2012 | $433M | +13.1% |
| 2011 | $383M | −1.1% |
| 2010 | $387M | +5.7% |
| 2009 | $366M | +5.6% |
| 2008 | $347M | −19.2% |
| 2007 | $430M | — |